Assistant Professor, Surgery, Perelman School of Medicine
Urology
Dr. Thomas J. Guzzo, MD
|
|
Give Review
Dr. Thomas J. Guzzo works in the field of Urology. He went to Temple University School of Medicine. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Most Compassionate Doctor". Thomas Guzzo is a published MD as well. He has 98 publications published. The latest was: Correlation of Peripheral Vein Tumour Marker Levels, Internal Iliac Vein Tumour Marker Levels and Radical Prostatectomy Specimens in Patients with Prostate Cancer and ... Doctor Thomas J. Guzzo, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Correlation of Peripheral Vein Tumour Marker Levels, Internal Iliac Vein Tumour Marker Levels and Radical Prostatectomy Specimens in Patients with Prostate Cancer and ...
- Percutaneous Renal Cryoablation: Short-Axis Ice-Ball Margin as a Predictor of Outcome.
- Intraoperative Molecular Diagnostic Imaging Can Identify Renal Cell Carcinoma.
- Complication and Readmission Rates following Same-Day Discharge after Percutaneous Renal Tumor Ablation.
- Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.
- Outcomes of radical cystectomy in potential candidates for Bladder preservation therapy.
- Impact of race on selecting appropriate patients for active surveillance with seemingly low-risk prostate Cancer.
- Factors influencing the length of stay after radical cystectomy: implications for Cancer care and perioperative management.
- A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate Cancer.
- The Presence of High-grade Prostatic Intraepithelial Neoplasia or Atypia on Prostate Biopsy Does Not Adversely Affect Prostatectomy Outcomes for Patients Otherwise Eli...
- An evidence-based strategy for the conservative management of the male patient with Incontinence.
- Multiple Repeat Prostate Biopsies and the Detection of Clinically Insignificant Cancer in Men With Large Prostates.
- Response of the human detrusor to stretch is regulated by TREK-1, a two-pore domain (K2P) mechano-gated potassium channel.
- The clinical presentation and outcome of urothelial atypia on biopsy of the Bladder.
- Application of a telomerase-based circulating tumor cell (CTC) assay in Bladder cancer patients receiving postoperative radiation therapy: A case study.
- Occult pelvic lymph node involvement in Bladder cancer: implications for definitive radiation.
- Optimizing Bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710.
- Renal mass size: concordance between pathology and radiology.
- Comprehensive handbook for developing a Bladder cancer cystectomy database.
- Small Renal masses: The promise of thulium laser enucleation partial nephrectomy.
- Percutaneous Computed Tomography-guided Renal Mass Radiofrequency Ablation versus Cryoablation: Doses of Sedation Medication Used.
- Effect of Practice Integration between Urologists and Radiation Oncologists on Prostate Cancer Treatment Patterns.
- Factors associated with satisfaction with prostate Cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
- Bladder preservation in the treatment of muscle-invasive Bladder cancer (MIBC): a review of the literature and a practical approach to therapy.
- Out-of-pocket expenses and treatment choice for men with prostate Cancer.
- Upfront Androgen Deprivation Therapy With Salvage Radiation May Improve Biochemical Outcomes in Prostate Cancer Patients With Post-Prostatectomy Rising PSA.
- Discordance Between Preoperative and Postoperative Bladder Cancer Location: Implications for Partial-Bladder Radiation.
- Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.
- Tumor enucleation for small Renal masses.
- A novel risk stratification to predict local-regional failures in urothelial carcinoma of the Bladder after radical cystectomy.
- Comparison of Prostate volume measured by transrectal ultrasound and magnetic resonance imaging: Is transrectal ultrasound suitable to determine which patients should ...
- Reported use of intravesical therapy for non-muscle-invasive Bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
- Ureteral Stents Placed at the Time of Urinary Diversion Decreases Postoperative Morbidity.
- Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating Renal mass size?
- Variation in Use of Androgen Suppression with External-Beam Radiotherapy for Nonmetastatic Prostate Cancer.
- Smoking Knowledge Assessment and Cessation Trends in Patients With Bladder Cancer Presenting to a Tertiary Referral Center.
- Impact on Renal Function of Percutaneous Thermal Ablation of Renal Masses in Patients with Preexisting Chronic Kidney Disease.
- Patient selection essential in optimizing the benefit of radical prostatectomy for patients with organ-confined prostate Cancer.
- Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate Cancer who would qualify for active surveillance.
- Bladder cancer: Improvements in clinical staging of muscle-invasive Bladder cancer.
- Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the Bladder.
- Repeat prostate biopsy and the incremental risk of clinically insignificant prostate Cancer.
- Major urologic problems in geriatrics: assessment and management.
- Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical Prostatectomy: an analysis using pro...
- Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage I nonseminomatous germ cell tumors.
- Long Term-Survival after Radical Prostatectomy for men with High Gleason Sum.
- Long-term survival after radical Prostatectomy for men with high Gleason sum in pathologic specimen.
- Prediction of mortality after radical Prostatectomy by Charlson comorbidity index.
- Prospects in percutaneous ablative targeting: comparison of a computer-assisted navigation system and the AcuBot Robotic System.
- Neuroendocrine tumor of the Bladder.
- The presence of circulating tumor cells does not predict extravesical disease in Bladder cancer patients prior to radical cystectomy.
- Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory Bladder cancer.
- A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients.
- Perioperative outcomes of elderly patients undergoing laparoscopic Renal procedures.
- Robotic surgical training of the urologic oncologist.
- The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with Renal cell carcinoma.
- Safety and efficacy of a surgeon-prepared gelatin hemostatic agent compared with FloSeal for hemostasis in laparoscopic partial nephrectomy.
- Laparoscopic radical nephrectomy for patients with pathologic T3b Renal-cell carcinoma: the Johns Hopkins experience.
- Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the Bladder.
- Application of Evicel to cavernous nerves of the rat does not influence Erectile function in vivo.
- Laparoscopic radical nephroureterectomy with en-bloc distal ureteral and Bladder cuff excision using a single position pneumovesicum method.
- Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy.
- A case of synchronous bilateral Testicular seminoma.
- Re: Guzzo TJ, Vira MA, Neway W, et al: Minimal tumor volume may provide additional prognostic information in good performance patients after radical Prostatectomy. Uro...
- Relationship of biochemical outcome to percentage of positive biopsies in men with clinically localized prostate Cancer treated with permanent interstitial brachytherapy.
- Modern management of pheochromocytoma.
- Minimal tumor volume may provide additional prognostic information in good performance patients after radical Prostatectomy.
- Initial experience with laparoscopic transvesical Ureteral reimplantation at the Children's Hospital of Philadelphia.
- Clinical approach to the Prostate: an update.
- Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate Cancer.
- Impact of multiple biopsy cores on predicting final tumor volume in prostate Cancer detected by a single microscopic focus of Cancer on biopsy.
- Re-examination of the Natural History of High-grade T1 Bladder Cancer using a Large Contemporary Cohort.
- Urinary markers for Bladder cancer.
- Synchronous metastatic Renal cell carcinoma to the genitourinary tract: two rare case reports and a review of the literature.
- Does race affect postoperative outcomes in patients with low-risk prostate Cancer who undergo radical prostatectomy?
- Robot assisted pyeloplasty in the infant-lessons learned.
- Bilateral single system ectopic ureters in a male infant.
- Granulosa cell tumor of the contralateral testis in a man with a history of cryptorchism.
- Laparoscopic and robotic complex upper-tract reconstruction in children with a duplex collecting system.
- The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
- Is the biopsy Gleason score important in predicting outcomes for patients after radical Prostatectomy once the pathological Gleason score is known?
- Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic Disease.
- The clinical and pathological history of prostate Cancer progression in men with a prior history of high grade prostatic intraepithelial neoplasia.
- Bladder cancer and the aluminium industry: a review.
- Enucleation of Renal cell carcinoma with ablation of the tumour base.
- Incidentally discovered Renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention.
- Urethral carcinosarcoma from Bladder carcinosarcomatous lesions: analysis of clinicopathological features.
- Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy.
- The impact of preoperative erectile dysfunction on survival after radical Prostatectomy.
- Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
- Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical Prostatectomy: implications for adjuvant radiother...
- Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transUrethral resection and radical cystectomy specimens.
- Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for Bladder cancer?
- Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
- Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors.
- Tumor enucleation: a safe treatment alternative for Renal cell carcinoma.
- Prostate-specific antigen surveillance among men with clinically localized prostate Cancer who do not receive initial treatment.
Schools
Temple University School Of Medicine
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystometry
- Cystotomy
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Semen (Hematospermia)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Most Compassionate Doctor
Education
-
University of Pennsylvania Health System -
Temple University School of Medicine
Hospital
-
Hospital of the University of Pennsylvania -
Philadelphia Veterans Affairs Medical Center -
Pennsylvania Hospital -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1144386533 | |
| NPPES Provider LastName | GUZZO | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 191045127 | |
| NPPES Provider State | PA | |
| Specialty Description | Urology | |
| Total Claim Count | 106.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 12.26 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144386533 |
| Last Name Of The Provider | GUZZO |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Milton E. Coll, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa M. Parrillo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. S B. Malkowicz, MD |
|
|
Dr. Joseph F. Harryhill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry E. Goldstein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bradley D. Figler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George W. Bradford, MD
This Doctor is OpenDoctor Recommended.
|